250 filings
Page 6 of 13
8-K
zqxyg8thfg4yo
19 Mar 19
Vaxart Announces Initiation of Bivalent Norovirus Vaccine
8:45am
8-K
skd1ei3cre
6 Feb 19
Vaxart Announces Fourth Quarter and Year-End 2018 Financial Results
4:24pm
8-K
7zmpuyya2a8
18 Jan 19
Departure of Directors or Certain Officers
4:14pm
8-K
8aeehzraas
18 Dec 18
Departure of Directors or Certain Officers
4:05pm
8-K
54pqs
20 Nov 18
Departure of Directors or Certain Officers
4:05pm
8-K
7snizxw
9 Nov 18
Vaxart Announces Third Quarter 2018 Financial Results
8:35am
8-K
97g5jbn
9 Aug 18
Vaxart Announces Second Quarter 2018 Financial Results
8:12am
8-K/A
0ikr8m
8 Jun 18
Financial Statements and Exhibits
6:18am
8-K
ogtbgu3fl322
6 Jun 18
Departure of Directors or Certain Officers
5:28pm
8-K
59f6kaupwkzspb6hg9b7
15 May 18
Vaxart Announces First Quarter 2018 Financial Results
12:00am
8-K
kqbhmyc5h4vfioxnhww
13 Apr 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K/A
yd8l3
2 Apr 18
Financial Statements and Exhibits
12:00am
8-K
7kbk3yojvcc19 9za
20 Feb 18
Combined Company Renamed Vaxart, Inc. and Will Begin Trading
12:00am
8-K
9h0v0gc
9 Feb 18
Aviragen Adjourns Special Meeting of Stockholders to Allow Stockholders to Consider Improved Merger Deal Terms
12:00am
8-K
obg5vb5728esmw
7 Feb 18
Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders
12:00am
8-K
kymc t4cz
6 Feb 18
Aviragen Adjourns Special Meeting of Stockholders Until February 9, 2018
12:00am
8-K
ioapawb h0mss
1 Feb 18
Aviragen Provides New Information Supporting Vote FOR Vaxart Merger
12:00am
8-K
h81ypp17
26 Jan 18
Aviragen Comments on ISS Report
12:00am
8-K
1lrdo5f7 9ytudsonvkp
24 Jan 18
Aviragen Therapeutics Issues Letter to Stockholders
12:00am
8-K
jz1jau1r8 mk7w
17 Jan 18
Other Events
12:00am